Auto - Parts
Compare Stocks
2 / 10Stock Comparison
PHIN vs DORM
Revenue, margins, valuation, and 5-year total return — side by side.
Auto - Parts
PHIN vs DORM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Auto - Parts | Auto - Parts |
| Market Cap | $2.97B | $3.72B |
| Revenue (TTM) | $3.56B | $2.15B |
| Net Income (TTM) | $141M | $190M |
| Gross Margin | 21.6% | 40.7% |
| Operating Margin | 9.0% | 15.6% |
| Forward P/E | 13.5x | 15.0x |
| Total Debt | $1.02B | $633M |
| Cash & Equiv. | $359M | $49M |
PHIN vs DORM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 23 | May 26 | Return |
|---|---|---|---|
| PHINIA Inc. (PHIN) | 100 | 248.8 | +148.8% |
| Dorman Products, In… (DORM) | 100 | 158.0 | +58.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PHIN vs DORM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PHIN is the clearest fit if your priority is income & stability.
- Dividend streak 3 yrs, beta 1.12, yield 1.3%
- Lower P/E (13.5x vs 15.0x)
- 1.3% yield; 3-year raise streak; the other pay no meaningful dividend
DORM carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 6.0%, EPS growth 8.1%, 3Y rev CAGR 7.1%
- 129.7% 10Y total return vs PHIN's 119.6%
- Lower volatility, beta 0.85, Low D/E 42.9%, current ratio 3.09x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.0% revenue growth vs PHIN's 2.4% | |
| Value | Lower P/E (13.5x vs 15.0x) | |
| Quality / Margins | 8.8% margin vs PHIN's 4.0% | |
| Stability / Safety | Beta 0.85 vs PHIN's 1.12, lower leverage | |
| Dividends | 1.3% yield; 3-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +94.3% vs DORM's +0.5% | |
| Efficiency (ROA) | 7.6% ROA vs PHIN's 3.6%, ROIC 13.9% vs 9.6% |
PHIN vs DORM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PHIN vs DORM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — PHIN and DORM each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PHIN is the larger business by revenue, generating $3.6B annually — 1.7x DORM's $2.2B. Profitability is closely matched — net margins range from 8.8% (DORM) to 4.0% (PHIN). On growth, PHIN holds the edge at +10.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $3.6B | $2.2B |
| EBITDAEarnings before interest/tax | $481M | $377M |
| Net IncomeAfter-tax profit | $141M | $190M |
| Free Cash FlowCash after capex | $305M | $71M |
| Gross MarginGross profit ÷ Revenue | +21.6% | +40.7% |
| Operating MarginEBIT ÷ Revenue | +9.0% | +15.6% |
| Net MarginNet income ÷ Revenue | +4.0% | +8.8% |
| FCF MarginFCF ÷ Revenue | +8.6% | +3.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +10.3% | +4.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +52.4% | -23.5% |
Valuation Metrics
PHIN leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 18.8x trailing earnings, DORM trades at a 22% valuation discount to PHIN's 24.2x P/E. On an enterprise value basis, PHIN's 8.3x EV/EBITDA is more attractive than DORM's 10.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.0B | $3.7B |
| Enterprise ValueMkt cap + debt − cash | $3.6B | $4.3B |
| Trailing P/EPrice ÷ TTM EPS | 24.19x | 18.75x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.45x | 15.05x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.25x |
| EV / EBITDAEnterprise value multiple | 8.31x | 10.41x |
| Price / SalesMarket cap ÷ Revenue | 0.85x | 1.75x |
| Price / BookPrice ÷ Book value/share | 1.98x | 2.59x |
| Price / FCFMarket cap ÷ FCF | 15.80x | 49.18x |
Profitability & Efficiency
DORM leads this category, winning 8 of 8 comparable metrics.
Profitability & Efficiency
DORM delivers a 13.1% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $9 for PHIN. DORM carries lower financial leverage with a 0.43x debt-to-equity ratio, signaling a more conservative balance sheet compared to PHIN's 0.64x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +8.9% | +13.1% |
| ROA (TTM)Return on assets | +3.6% | +7.6% |
| ROICReturn on invested capital | +9.6% | +13.9% |
| ROCEReturn on capital employed | +9.9% | +18.5% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.64x | 0.43x |
| Net DebtTotal debt minus cash | $661M | $584M |
| Cash & Equiv.Liquid assets | $359M | $49M |
| Total DebtShort + long-term debt | $1.0B | $633M |
| Interest CoverageEBIT ÷ Interest expense | 3.37x | 8.24x |
Total Returns (Dividends Reinvested)
PHIN leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PHIN five years ago would be worth $21,957 today (with dividends reinvested), compared to $11,922 for DORM. Over the past 12 months, PHIN leads with a +94.3% total return vs DORM's +0.5%. The 3-year compound annual growth rate (CAGR) favors PHIN at 30.0% vs DORM's 12.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +21.7% | +0.3% |
| 1-Year ReturnPast 12 months | +94.3% | +0.5% |
| 3-Year ReturnCumulative with dividends | +119.6% | +41.6% |
| 5-Year ReturnCumulative with dividends | +119.6% | +19.2% |
| 10-Year ReturnCumulative with dividends | +119.6% | +129.7% |
| CAGR (3Y)Annualised 3-year return | +30.0% | +12.3% |
Risk & Volatility
Evenly matched — PHIN and DORM each lead in 1 of 2 comparable metrics.
Risk & Volatility
DORM is the less volatile stock with a 0.85 beta — it tends to amplify market swings less than PHIN's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PHIN currently trades 96.6% from its 52-week high vs DORM's 74.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.12x | 0.85x |
| 52-Week HighHighest price in past year | $81.11 | $166.89 |
| 52-Week LowLowest price in past year | $40.36 | $98.44 |
| % of 52W HighCurrent price vs 52-week peak | +96.6% | +74.6% |
| RSI (14)Momentum oscillator 0–100 | 69.8 | 71.2 |
| Avg Volume (50D)Average daily shares traded | 357K | 273K |
Analyst Outlook
PHIN leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates PHIN as "Hold" and DORM as "Buy". Consensus price targets imply 12.4% upside for DORM (target: $140) vs 7.8% for PHIN (target: $85). PHIN is the only dividend payer here at 1.34% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $84.50 | $140.00 |
| # AnalystsCovering analysts | 5 | 16 |
| Dividend YieldAnnual dividend ÷ price | +1.3% | — |
| Dividend StreakConsecutive years of raises | 3 | 2 |
| Dividend / ShareAnnual DPS | $1.05 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +6.8% | +1.1% |
PHIN leads in 3 of 6 categories (Valuation Metrics, Total Returns). DORM leads in 1 (Profitability & Efficiency). 2 tied.
PHIN vs DORM: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is PHIN or DORM a better buy right now?
For growth investors, Dorman Products, Inc.
(DORM) is the stronger pick with 6. 0% revenue growth year-over-year, versus 2. 4% for PHINIA Inc. (PHIN). Dorman Products, Inc. (DORM) offers the better valuation at 18. 8x trailing P/E (15. 0x forward), making it the more compelling value choice. Analysts rate Dorman Products, Inc. (DORM) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PHIN or DORM?
On trailing P/E, Dorman Products, Inc.
(DORM) is the cheapest at 18. 8x versus PHINIA Inc. at 24. 2x. On forward P/E, PHINIA Inc. is actually cheaper at 13. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — PHIN or DORM?
Over the past 5 years, PHINIA Inc.
(PHIN) delivered a total return of +119. 6%, compared to +19. 2% for Dorman Products, Inc. (DORM). Over 10 years, the gap is even starker: DORM returned +129. 7% versus PHIN's +119. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PHIN or DORM?
By beta (market sensitivity over 5 years), Dorman Products, Inc.
(DORM) is the lower-risk stock at 0. 85β versus PHINIA Inc. 's 1. 12β — meaning PHIN is approximately 31% more volatile than DORM relative to the S&P 500. On balance sheet safety, Dorman Products, Inc. (DORM) carries a lower debt/equity ratio of 43% versus 64% for PHINIA Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PHIN or DORM?
By revenue growth (latest reported year), Dorman Products, Inc.
(DORM) is pulling ahead at 6. 0% versus 2. 4% for PHINIA Inc. (PHIN). On earnings-per-share growth, the picture is similar: PHINIA Inc. grew EPS 84. 1% year-over-year, compared to 8. 1% for Dorman Products, Inc.. Over a 3-year CAGR, DORM leads at 7. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PHIN or DORM?
Dorman Products, Inc.
(DORM) is the more profitable company, earning 9. 6% net margin versus 3. 7% for PHINIA Inc. — meaning it keeps 9. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DORM leads at 16. 8% versus 8. 0% for PHIN. At the gross margin level — before operating expenses — DORM leads at 41. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PHIN or DORM more undervalued right now?
On forward earnings alone, PHINIA Inc.
(PHIN) trades at 13. 5x forward P/E versus 15. 0x for Dorman Products, Inc. — 1. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DORM: 12. 4% to $140. 00.
08Which pays a better dividend — PHIN or DORM?
In this comparison, PHIN (1.
3% yield) pays a dividend. DORM does not pay a meaningful dividend and should not be held primarily for income.
09Is PHIN or DORM better for a retirement portfolio?
For long-horizon retirement investors, PHINIA Inc.
(PHIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 12), 1. 3% yield, +119. 6% 10Y return). Both have compounded well over 10 years (PHIN: +119. 6%, DORM: +129. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PHIN and DORM?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
PHIN pays a dividend while DORM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.